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Anthramycin is a benzodiazepine alkaloid with
potent antitumor and antibiotic activity pro-
duced by the thermophilic actinomycete Strep-
tomyces refuineus sbsp. thermotolerans. In this
study, the complete 32.5 kb gene cluster for the
biosynthesis of anthramycin was identified by
using a genome-scanning approach, and clus-
ter boundaries were estimated via comparative
genomics. A l-RED-mediated gene-replace-
ment system was developed to provide sup-
porting evidence for critical biosynthetic genes
and to validate the boundaries of the proposed
anthramycin gene cluster. Sequence analysis
reveals that the 25 open reading frame anthra-
mycin cluster contains genes consistent with
the biosynthesis of the two halves of anthramy-
cin: 4 methyl-3-hydroxyanthranilic acid and a
‘‘dehydroprolineacrylamide’’moiety.Thesenon-
proteinogenic amino acid precursors are con-
densed by a two-module nonribosomal peptide
synthetase (NRPS) terminated by a reductase
domain, consistent with the final hemiaminal
oxidation state of anthramycin.
INTRODUCTION
Benzodiazepine-containing natural products are pro-
duced by a variety of bacteria and fungi of terrestrial and
aquatic origin and are notable for their potent antimicro-
bial and antitumor activities. The marked biological activ-
ity in this family of natural products is perhaps unsurpris-
ing considering the ubiquity of peripheral benzodiazepine
receptors, which are linked to a number of significant bio-
chemical processes [1, 2], and the ability of some benzo-
diazepines to react irreversibly with DNA. Anthramycin,
the first known bacterially produced benzodiazepine alka-
loid, is a pyrrolo [1,4]-benzodiazepine from Streptomyces
refuineus sbsp. thermotolerans [3–5]. Anthramycin activity
results from noncovalent binding to TA-rich regions in the
minor groove of DNA followed by irreversible covalent
modification of the N2-amino group of a vicinal guanineChemistry & Biology 14, 6[6]. This mode of action is shared by a family of pyrrolo-
benzodiazepine containing natural products that includes
sibiromycin and tomaymycin and is likely responsible for
their varied antibiotic, antiviral, and antitumor activities
[7]. While the inherent cardiotoxicity of anthramycin pre-
cludes its broad application in the clinic, new classes of
antitumor benzodiazepine class compounds have been
discovered that, to date, do not posses this disadvantage.
For instance ECO-4601, a farnesylated benzodiazepinone
natural product from Micromonospora with activity
against several cancer cell lines, is currently in clinical
trials for the treatment of brain, breast, prostate, and
pancreatic tumors [8–10].
Hurley et al. have demonstrated that anthramycin is
composed of two halves, each derived by oxidative ring
opening of an aromatic amino acid followed by sub-
sequent biosynthetic tailoring steps [11] (Figure 1). The
4-methyl-3-hydroxyanthranilic acid half of anthramycin is
derived from tryptophan via the primary metabolic kynur-
enine pathway followed by S-adenosylmethionine depen-
dent aromatic C-methylation [12]. The ‘‘dehydroproline
acrylamide’’ moiety is derived from tyrosine via oxidative
ring opening of DOPA [13]. The pattern of tyrosine incor-
poration of this amino acid into anthramycin is highly
analogous to the pattern of incorporation in the antibiotic
metabolite lincomycin, which contains an analogous 4-
propyl-4,5-dehydroproline moiety [14]. The parallel nature
of these pathways is also supported by incorporation of
CH3-labeled methionine into the C-terminal carboxamide
of anthramycin and terminal methyl group of lincomycin
propyl side chain (Figure 1).
Despite these insightful precursor incorporation stud-
ies, insight toward understanding the pathway for forma-
tion of the benzodiazepine skeleton has not progressed
since the original forays. Here, we report the sequencing,
validation, and analysis of the gene cluster for anthramy-
cin biosynthesis. The 32.5 kb gene cluster is comprised
of unambiguous gene cassettes for the biosynthesis of
the two noncanonical amino acid halves of anthramycin
in addition to a reductase-terminated bimodular non-
ribosomal peptide synthetase system for benzodiazepine
ring formation. This study provides, to our knowledge,
the first bacterial biosynthetic gene cluster for a biogenic
benzodiazepine and provides an NRPS megasynthetase
system for a known natural product in a thermophilic
actinomycete.91–701, June 2007 ª2007 Elsevier Ltd All rights reserved 691
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Identification and Cloning of the Anthramycin Gene
Cluster from S. refuineus
The complete gene cluster for anthramycin biosynthesis
was identified by a rapid genome-scanning method [15].
Briefly, a two-tiered genomic DNA library (of 1.5–3 kb
and 30–50 kb fragments) was constructed from sonically
and enzymatically sheared high-molecular-weight DNA,
respectively, isolated from Streptomyces refuineus sbsp.
Figure 1. Biosynthetic Overview Based on Isotopic Incorpo-
ration Studies692 Chemistry & Biology 14, 691–701, June 2007 ª2007 Elsevthermotolerans. The short insert library was cloned into
a pBluescript SK+ derivative, and a total of 486 genomic
sequence tags (GSTs) were generated by sequencing
randomly selected clones. Clones were analyzed for
sequence similarity to secondary metabolic genes in the
NCBI nonredundant protein database. In this manner,
a single GST was identified containing sequence similarity
to the predicted requisite NRPS. An 864 member cosmid
insert library, corresponding to approximately 3- to 4-fold
coverage, was created from the large fragment DNA, and
the NRPSGSTwas labeled and used as colony-hybridiza-
tion probe for the identification of anthramycin cluster-
containing cosmid candidates.
Sequencing and Overview of the Anthramycin
Biosynthetic Gene Cluster
Two cosmids were identified by colony hybridization with
the NRPS GST and entirely sequenced by a shot-gun se-
quencing approach. Neighboring cosmids were identified
by colony hybridization to provide two overlapping cos-
mids that putatively spanned a gene cluster comprising
genes predicted to be required for anthramycin biosyn-
thesis, including genes with translated similarity to known
enzymes in 3-hydroxyanthranillic acid biosynthesis,
proteins associated with pyrrolyl-functional metabolite
biosynthesis (lincomycin) and NRPS enzymatic systems
(Figure 2 and Table 1). The boundaries of the gene cluster
were deduced by comparative genomics. Genes with
high-translated sequence similarity to bacterial primary
metabolism in the nonredundant GenBank database,
and not to secondary metabolism genes in GenBank,
were putatively assigned to primary metabolism.
Gene-Replacement Methodology
and Boundary Validation
Estimated boundaries of the anthramycin gene cluster
were validated by a series of PCR-targeted gene-replace-
ment experiments. The two cosmids containing the puta-
tive anthramycin biosynthetic genes were retrofitted with
an origin of intergeneric transfer, oriT, in order to facilitate
subsequent conjugation into S. refuineus. The general
gene-replacement strategy was based on the well-estab-
lished l-Red (Red/ET) system (Figure 3) [16, 17]. Briefly,
the apramycin resistance gene aac(3)IV, or a cassette
containing the apramycin-resistance gene aac(3)IV and
oriT, was amplified from plasmid pIJ773 with the 39 bpFigure 2. Proposed Biosynthetic Gene Cluster for Anthramycin Is Contained on Two Cosmids 024CO and 024CA
Red boxes summarize gene replacement mutants created in this study; +/ indicates presence or absence of anthramycin in extracts of replacement
mutants as analyzed by bioactivity and HPLC/MS.ier Ltd All rights reserved
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ORF #AA GenBank Homology % Identity/Similarity Proposed Function
AS10 138 AAU19321.1 46/68 unknown, hypothetical protein
1 624 BAB12569.1 57/68 amidotransferase
2 500 CAD30313.1 aldehyde dehydrogease
3 354 EAO60654.1 50/65 alcohol dehydrogenase
4 410 CAJ23858.1 49/63 Cytochrome P-450 hydroxylase
5 352 487713 79/87 lmbA, methyltranferase
6 621 CAA55746.1 73/80 lmbW, unknown function
7 487 ABF90321.1 38/54 FAD oxidoreductase
8 764 AAL06654.1 59/75 drug-resistence pump
9 256 CAB55527.1 27/40 putative hydroxylase/glyoxylase
10 377 EAL16816.1 41/66 transporter
11 89 – – none
12 169 CAA55747.1 48/63 lmbB1, L-DOPA 2,3-dioxygenase
13 302 CAA55748.1 42/54 lmbB2, L-tyrosine 3-hydroxylase.
14 297 CAA55772.1 50/63 lmbY, unk. lincomycin biosynth.
15 276 CAA55771.1 34/41 lmbX, unk. lincomycin biosynth.
16 413 42543461 37/57 kynureninase
17 261 4753870 37/52 tryptophan 2,3-dioxygenase
18 58 – – none
19 348 37542638 43/63 aromatic C-methyltransferase
20 296 EAU10758.1 36/49 aryl formamidase
21 600 CAD92850.1 35/51 NRPS
22 1146 ABF90459.1 32/46 NRPS
23 500 ABF39686.1 32/49 kynurenine 3-monooxygenase
24 475 ABF87356.1 36/50 flavin-containing oxidoreductase
25 273 BAC79018.1 46/64 repressor-response regulator
S11 174 BAC69182.1 63/68 Zn-dependent hydrolase
S12 199 EAU12469.1 31/53 unknown, hypothetical proteinflanking primers homologous to the area for replacement
(see Table S1 in the Supplemental Data available with
this article online). Transformation of the linear PCR prod-
uct into an E. coli BW25113/pIJ790 strain bearing the tar-
get cosmid and expressing l-RED recombinase facilitated
efficient double crossover recombination within the tar-
get cosmid. Gene replacement was assayed by selecting
for apramycin resistance, and correct insertion was
confirmed by PCR amplification. These suicide cosmids
were then transferred into S. refuineus sbsp. thermotoler-
ans by intergeneric transfer and double crossover events
were selected by assaying for resistance to apramycin
and sensitivity to the cosmid vector kanamycin resistance.
PCR analysis of sensitive colonies was performed as de-
scribed in Experimental Procedures through genomic
DNA amplification with primers internal to the aac(3)IV
gene and the adjacent anthramycin biosynthetic genes
(Table S2).Chemistry & Biology 14, 6The genomic deletion of NRPS genes by replacement
of orf21/orf22 with the aac(3)IV gene resulted in a mutant
incapable of producing anthramycin. Duplicate butanol
extracts of cultures of (orf21/orf22::aac(3)IV) were com-
pared to control cultures of the wild-type strain via TLC
bioautography with B. subtillis and HPLC/MS. Similarly,
cluster boundary determinations were supported by
gene replacement of orfAS10 and orf1, on the upstream
side of the anthramycin gene cluster, and orfS11, orf23,
and orf24 on the downstream side. The orf25 gene was
not selected for gene replacement due to its high-
sequence similarity to known secondary metabolite
regulatory genes. Loss of anthramycin production was
observed only in (orf1::aac(3)IV/oriT), (orf23::aac(3)IV/oriT),
and (orf24::aac(3)IV/oriT) gene-replacement mutants, indi-
cating that sequence-based analysis correctly approxi-
mated the boundaries of the anthramycin biosynthetic
gene cluster.91–701, June 2007 ª2007 Elsevier Ltd All rights reserved 693
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and Detection of Anthramycin
(A) Anthramycin production (ESI+ = 316) in WT
(blue) versus (orf1::aac(3)IV) (red).
(B) Anthramycin production in (orf24::aac(3)IV/
oriT) (red) with chemical complementation of
compound 9 (blue).Chemical Complementation
The retinue of putative anthranilic acid biosynthetic
mutants created by gene replacement was analyzed by
a series of chemical-complementation experiments. Dis-
rupted genes hypothesized to be involved in the biosyn-
thesis of the anthranilate-derived pathway of anthramycin
biosynthesis (see below) include orf23, orf24, and orf19.
Four possible intermediates, L-kynurenine 8, 3-hydroxy-
L-kynurenine 9, hydroxyanthranilic acid 10, and syntheti-
cally prepared 4-methyl-3-hydroxyanthranilic acid 11
[18], were tested for their ability to complement the three
gene-replacement mutants in precursor feeding experi-
ments. Extracts prepared from gene-replacement mu-
tants grown in the presence of precursors were analyzed
by TLC-bioautography (anti-Bacillus) and HPLC/MS. De-
tection of benzodiazepine mass ions unambiguously
demonstrated the presence or absence of anthramycin
(ES+ = 316 Da) or desmethylanthramycin (ES+ = 302 Da)
in culture extracts (Figure 3). Anthramycin equilibrates in
the extracts between several isomeric forms in methanol,
including the aldehyde (open), hemiaminal, and methyl
ether (closed) forms, all of which were observable under
our chromatographic conditions. The results of the anthra-
nilate pathway chemical-complementation experiments
are summarized in Figure 4. In addition to providing evi-
dence for the involvement of orf23 and orf24 in the biosyn-694 Chemistry & Biology 14, 691–701, June 2007 ª2007 Elsevithesis of the anthranilate-derived portion of anthramycin,
these data demonstrate that in the case of orf19, orf23,
and orf24, these disruptions resulted in minimal polar
effects in the anthramycin pathway.
DISCUSSION
With the complete gene cluster for anthramycin in hand,
the outline for the pathway of assembly of the benzodiaz-
epine structure of anthramycin begins to take shape. The
anthramycin biosynthetic gene cluster is comprised of
25 genes including a bimodular NRPS system, genes for
4-methyl-3-hydroxy-anthranilic acid biosynthesis, and a
series of genes for the biosynthesis of the pyrrolylacryla-
mide moiety. Additionally, gene candidates for regulation,
resistance, and transport can be suggested by sequence
analysis.
The two amino acid-derived halves of anthramycin are
likely to be activated via adenylation and thioesterification
on the bimodular megasynthetase. While the precise iden-
tities of the two amino acid NRPS substrates are yet to be
determined, it is likely that the first module activates the
4-methyl-3-hydroxyanthranilic acid, or a closely related
precursor, which becomes thioesterified on the first T do-
main, and the second module activates a dehydroproline
acrylamide precursor. C-methylation of anthranilic acider Ltd All rights reserved
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of Methylanthranilic Acid Biosynthesis,
and below, Summary of Chemical
Complementation Experiments
Theoretical versus observed prediction of
masses is based on this scheme, though other
schemes are possible.may occur prior or subsequent to benzodiazepine-core
formation. Similarly, the dehydroproline acrylamide moi-
ety may be fully elaborated prior to activation and thioes-
terification, as apparently occurs in the biosynthesis of the
structurally similar lincomycin natural products, or multi-
ple modifications (oxidation, amidation) may take place
following peptide-bond synthesis. Somewhat unusually,
the anthramycin NRPS contains a putative terminal
NADH-binding domain in place of the traditional thioester-
ase domain. This is consistent with the oxidation state of
the hemiaminal of anthramycin and suggests that the di-
peptide is released by a reductive mechanism. Intramo-
lecular addition of the anthranillate-derived arylamine to
the dehydroproline acrylamide aldehyde most likely com-
pletes the formation of the seven-membered hemiaminal
benzodiazepine skeleton of anthramycin.
4-Methyl-3-Hydroxyanthranilic Acid Biosynthesis
The 4-methyl-3-hydroxyanthranilic acid moiety in anthra-
mycin is shared by a number of peptide secondary meta-
bolites, notably the venerable Streptomyces secondary
metabolite actinomycin [19]. Several of the genes puta-
tively assigned for the biosynthesis of 4-methyl-3-hydr-
oxyanthranilic acid are comprised of homologs of primary
metabolic genes involved in 3-hydroxyanthranilic acid bio-
synthesis (orf16, orf17, orf20, and orf23) (Figure 4). As this
metabolite is of central importance in primary metabolism
as a progenitor of the nicotinate-derived cofactors, these
genes may represent additional copies of these essential
housekeepinggenes.Alternatively, the substrate specificity
of these genes and/or the order of their application in the
pathway may differ from the primary metabolic paradigm.
Due to clustering and sequence analysis, we speculated
that ORF24 may also be involved in 4-methyl-3-hydroxy-
anthranilic acid biosynthesis. However, the precise role
of the orf24 gene in anthramycin biosynthesis is less clear.
The translated gene product has high similarity to flavin-
containing L-amine oxidases, and we speculate that
ORF24 may also play a role in the oxidative generation
of 8 and 9 via an oxidative cleavage mechanism.Chemistry & Biology 14,The only remaining activity required to biosynthesize the
aromatic half of anthramycin is a C-methyltransferase to
append the aryl methyl group. There are two putative
methyltransferase genes in the anthramycin gene cluster,
orf5 and orf19. ORF5 is likely to be involved in dehydropro-
line acrylamide biosynthesis as it is 73% identical to
LmbW of lincomycin 4-propyl-4,5-dehydroproline biosyn-
thesis (see below). Hence, by process of elimination,
ORF19 is a likely candidate for the requisite aromatic
C-methylase.Thishypothesis is supportedby thesequence
similarity of ORF19 to SfcF (43%/63%), a putative aro-
matic C-methyltransferase implicated in the biosynthesis
of safracin in Pseudomonas fluorescens [20]. 3-hydroxy-
anthranilic acid is a known primary metabolite, and we
have identified four genes with high translated sequence
similarity to the primary metabolic pathway enzymes.
However, the question of timing of events, particularly
methylation, remains unknown. In Figure 4, we delineate
two general possibilities. In pathway A, C-methylation is
postulated to occur subsequent to 3-hydroxyanthranilic
acid formation, preserving the order of primary metabolic
precedent. In this case, introduction of aryl C-methyl may
occur via intermediate 11, by direct methylation of 10, or
may occur during or after dipeptide assembly. In pathway
B, methylation is inserted at an unknown position in the
primary anthranilic acid pathway, causing downstream di-
vergence of enzymes specificity in the biosynthesis of 11.
To support the roles of these genes in 4-methyl-3-
hydroxyanthranilic acid biosynthesis and to gain insight
into the timing of methylation, gene-deletion mutants
were supplemented with exogenously added anthranilate
pathway intermediates and 8, 9, 10, and 11. 3-hydroxy-
L-kynurenine 9 and 3-hydroxyanthranilic acid 10 were
demonstrated to restore benzodiazepine biosynthesis
when added to cultures of the (orf19::aac(3)IV), (orf23::
aac(3)IV/oriT), and (orf24::aac(3)IV/oriT) mutants, as dem-
onstrated by analysis of culture extracts by TLC bioautog-
raphy and confirmed with HPLC/MS, whereas compound
8 and 3-methyl-4-hydroxyanthranilic acid 11 failed to
complement any of the mutants. For pathway A to be691–701, June 2007 ª2007 Elsevier Ltd All rights reserved 695
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of 8 must be unfavorable under our fermentation condi-
tions, or the order of aryl oxidation must differ slightly
from primary metabolism (for instance, 7may be the sub-
strate for hydroxylation instead of 8). Furthermore, in the
context of pathway A, these data suggest that C-methyl-
ation does not proceed via intermediate 11. For pathway
B to be operative and to encompass this data, it must
be postulated that the transport of intermediate 11 is un-
favorable under our fermentation conditions. Unfortu-
nately, we were unable to detect accumulated intermedi-
ates (with one notable exception below) in our gene-
disrupted strains. However, since the intermediacy of
compound 9 is legitimized by its ability to complement an-
thramycin biosynthesis, we favor pathway A. Further bio-
chemical experiments are needed to fully resolve the issue
of the timing of methylation and the intermediacy of 11.
While feeding studies for the anthranilate-derived half of
anthramycin may be obfuscated by the similarity of this
pathway to primary metabolism, the possibility of shunt
pathways, and issues pertaining to transport, it is
unambiguous that benzodiazepine biosynthesis can be
restored in all three mutants by the addition 9 and 10,
indicating that targeted gene disruptions resulted in mini-
mal polar effects. In the case of complementation of the
orf23 and orf24 mutants, but not the orf19 mutant, with
10, we were able to confirm the production of a major
shunt antibiotic desmethylanthramycin (previously re-
ferred to as ‘‘yellow pigment’’ [5]) that accumulated to
high levels in this experiment. We therefore propose that
ORF19 is the secondary metabolic aromatic C-methyl-
transferase using an unknown aromatic intermediate
as a substrate. It may be noted that this activity has
been previously demonstrated in actinomycin-producing
Streptomyces, but the sequence of the isolated enzyme
has yet to be reported [18].
Dehydroproline Acrylamide Biosynthesis
The dehydroproline acrylamide moiety biosynthetic clus-
ter is evidenced by a group of genes with high-sequence
similarity to six genes involved in 4-propyl-4,5-dehydro-
proline biosynthesis in lincomycin [21]. The similarity is
not surprising considering the correspondence in precur-
sor incorporation experiments in these two pathways,
which demonstrate that the respective dihydropyrrolyl
components of these natural products are derived from ty-
rosine and that the acrylamide carbonyl and the propyl
methyl group are both derived from methionine. The pre-
cise sequence of biotransformations leading to dehydro-
proline acrylamide remains to be determined, but it is likely
that the first two steps of dehydroproline acrylamide bio-
synthesis are analogous to the corresponding pathway
in lincomycin biosynthesis, in which 2,3-extradiol cleav-
age of dihydroxyphenylalanine results in the formation of
imine 12. While functional analysis of the majority of lin-
comycin biosynthetic genes has not been performed, it
has been demonstrated that lmbB2 and lmbB1 (similar
to orf13, orf12) encode enzymes that convert L-tyrosine
to L-dihydroxyphenylalanine and catalyze 2,3-extradiol696 Chemistry & Biology 14, 691–701, June 2007 ª2007 Elseviecleavage, respectively [22, 23]. Labeling studies have
demonstrated loss of glyoxlyate or formal equivalent in
the lincomycin pathway, andwe suggest that anthramycin
ORF5, with 79% sequence identity to lincomycin methyl-
transferase LmbA, likely methylates intermediate 13 to
a,b-unsaturated imine 14, a possible branch point at
which the biosynthetic pathways of lincomycin and an-
thramycin diverge (Figure 5). In the case of lincomycin,
the 4-propyl-4,5-dehydroproline precursor 17 may be
generated by conjugate reduction of unsaturated imine
14. In the case of anthramycin, tautomerization of imine
14 may yield a dieneamine as an appropriate substrate
for allylic methyl oxidation by ORF4. This putative P-450
hydroxylase is suggestively clustered with a series of
enzymes (orf1-3-encoding proteins) with high sequence
similarity to characterized alcohol dehydrogenase, alde-
hyde dehydrogenase, and amidotransferase enzymes,
which are all formally required to complete the synthesis
of acrylamide 16 from allylic alcohol 15.
Of note, however, no accumulation of dehydroproline
acrylamide (or any other new major metabolite) was ob-
served in HPLC/MS analysis of duplicate butanol extracts
of anthranilate disruptionmutants. Thismay be a reflection
of inefficient partitioning of this zwitterionic compound in
butanol, low levels of accumulation of the intermediate,
or the possibility that the true substrate for the NRPS cat-
alyzed condensation reactionmay in fact be a precursor of
amide 16 in final structure anthramycin.
Nonribosomal Peptide Synthetase
The NRPS system is the preferred paradigm for the bio-
synthesis of small peptides in bacteria [24–26]. In these
systems, a modular thiotemplate mechanism is used
for assembly of structurally diverse peptides. Domains
for adenylation (A domain), amide bond condensation
(C domain), and thioesterification (T domain) are concat-
enated, often collinearly, into ‘‘modules,’’ each module
corresponding to a peptide homologation step. The re-
lease of bound peptide intermediates is catalyzed by ter-
minal thioesterase domains (TE). NRPS systems have
been shown to accommodate an increasing inventory
of domains for modification of the elongating peptide
intermediates including heterocylization, oxidation, and
methylation domains, to name a few. The anthramycin
cluster contains two NRPS genes encoding a compact
series of six catalytic domains in colinear order on two
separate modules orf20 (A-T) and orf21 (C-A-T-Re)
(Figure 6). Notably, the incorporation of an unusual C-ter-
minal reductase domain (Re) in the second module
suggests that release from the megasynthetase is ac-
complished by reduction of the phosphopantathienyl
tethered dipeptide, rather than the hydrolysis of a benzo-
diazepinone intermediate, which would be evidenced
by a terminal thioesterase (TE) domain. This reductive
release mechanism has also been proposed to be oper-
ative in saframycin [27], mycochelin [28], nostocyclo-
peptide [29], and equisetin [30] NRPS proteins, which
also encode terminal reductase domains. Analysis of
the anthramycin NRPS A-domains by the establishedr Ltd All rights reserved
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Acrylamide Pathway in which 14 Is
Hypothesized to Be the Common Inter-
mediate in Anthramycin and Lincomycin
ORF12, ORF13, ORF14, and ORF5 possess
significant sequence similarity to the linco-
mycin biosynthesis pathway.predictive homology modeling method [31, 32] demon-
strates relatively low similarity to known A domains in-
cluding, notably, actinomycin synthetase, which has
been previously demonstrated to activate 4-methyl-3-hy-
droxy-anthranilic acid [33]. A notable feature of the ho-
mology model for the first A domain is that it is missing
critical Asp-235, which is generally believed to interact
with the a-amino group of the amino acid substrate.
This is unsurprising considering the structural divergence
of b-amino acid that is proposed to serve as substrate.
Regulation and Resistance
The similarity of ORF8 to the UvrA [34] component of the
excision nucleotide repair system and the daunorubicin-
resistance protein DrrC [35] suggests a role in resistance.
Adjacent genes orf9 and orf10may also be components of
the resistance system, encoding proteins with similarity to
bleomycin-resistance proteins and drug-efflux proteins,
respectively. orf25 encodes an amino acid sequence
with N-terminal sequence similarity to the receiver domain
and C-terminal similarity to the DNA-binding domain of
a bacterial two-component response system [36] and
thus may play a role in coordinating anthramycin biosyn-
thesis with environmental signals.
SIGNIFICANCE
The benzodiazepine natural products are broadly
cytotoxic and have been found to have marked selec-Chemistry & Biology 14, 6tivity for various cancer cell lines in addition to their
antibacterial and antiviral properties. Due to issues
of general cytotoxicity and cardiotoxicity, the anthra-
mycin class of natural products has not found human
clinical application. However, new promising mem-
bers of benzodiazepine natural products continue to
be discovered. For example, ECO-4601 is a benzo-
diazepinone with high selectivity for human glioblas-
toma cell lines and is currently in Phase I clinical trials
for treatment of various types of cancer. The deduc-
tion of the anthramycin gene cluster provides insight
into the biosynthesis of this important class of natural
products and will facilitate the identification of new
benzodiazepine compounds from microbial genome
projects. In addition, most known actinomycetes are
strictly mesophillic, with an optimum growth tempera-
ture range of 26C–30C. The anthramycin-producing
organism Streptomyces refuineus, originally isolated
from an exothermically decaying compost heap, is
moderately thermophilic, preferring to grow and to
produce anthramycin at 47C. However, prior to this
study, methods for the transformation and genetic
manipulation of thermophilic actinomycetes have
not been described. Thermophilic actinomycetes
may have utility as hosts for heterologous expression
of natural product gene clusters. Moreover, the
practical advantages for structural studies with
enzymes from thermophilic microorganisms are well
precedented.91–701, June 2007 ª2007 Elsevier Ltd All rights reserved 697
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Bacterial Strains and Culture Conditions
Streptomyces refuineus var. thermotolerans (NRRL 3143) and its deriv-
atives were maintained and grown on either ISP4 medium or TSB me-
diumwith appropriate antibiotics at 37C. For anthramycin production,
S. refuineus and its derivatives were cultured in production medium
(1% corn starch, 2% peptonized milk, and 0.3% yeast extract at pH
Figure 6. Nonribosomal Assembly and Reductive Release of
Anthramycin698 Chemistry & Biology 14, 691–701, June 2007 ª2007 Elsevie7.0) at 47C. Bacillus sp. TA (NRRL B-3167) was cultured in nutrient
agar and used as a test organism for the antibacterial activity of
S. refuineus and its derivatives. DH10B (Invitrogen) served as host
for S. refuineus genomic library construction. E. coliBW25113 contain-
ing plasmid pIJ790 was used for targeted gene disruption in S. refui-
neus. E. coli ET12567 containing the RP4 derivative pUZ8002 was
used for intergeneric conjugation between E. coli and S. refuineus.
E. coli strains were grown in LB medium supplemented with appropri-
ate antibiotics for selection of plasmids.
Plasmids and General DNA Procedures
SuperCos-1 derivatives were used to construct genomic libraries of
S. refuineus. DNA isolation and manipulation, cosmid preparation,
and gel electrophoresis were conducted according to standard
methods. Cosmid DNA was isolated from E. coli strains by using
Qiagen miniprep kits. Isolation of DNA fragments from agarose was
carried out by using Qiagen gel extraction kit. Genomic DNA from
S. refuineus and its derivatives were isolated by using Wizard genomic
DNA purification kit (Promega).
Preparation of Possible Biosynthetic Intermediates of
Anthramycin
L-kynurenine, 3-hydroxy-L-kynurenine, hydroxyanthranilic acid were
purchased directly from Sigma Corporation. 4-methyl-3-hydroxyan-
thranillic acid was prepared by catalytic hydrogenation of 4-methyl-
3-hydroxy-2-nitrobenzoic acid (Aldrich, Inc.) with Pd/C and H2 at 1
atm in ethanol [18].
Genomic Sampling Library Construction and Screening
Highmolecular weight DNAwas isolated by established protocols [37],
and its integrity was verified by field inversion gel electrophoresis
(FIGE) with preset program number 6 (switch time ramp 0.4–1.5 s,
linear shape, forward voltage 180, reverse voltage 120) of the FIGE
MAPPER power supply (BIORAD, Inc.).
To generate the small insert DNA library, genomic DNA was ran-
domly sheared by sonication. DNA fragments having a size range
between 1.5 and 3 kb were fractionated on agarose. The ends of the
DNA fragments were repaired by using T4 DNA polymerase (Roche)
as described by the supplier. The repaired DNA fragments were
subcloned into a derivative of pBluescript SK+vector (STRATAGENE).
Plasmid DNA carrying the Streptomyces refuineus genomic DNA frag-
ments was extracted by the alkaline lysis method, and the insert size of
1.5 to 3 kb was confirmed by electrophoresis on agarose gels. Using
this procedure, a library of small-size random genomic DNA fragments
representative of the entire genome of Streptomyces refuineus was
generated.
The small insert DNA library was analyzed by sequence determina-
tion of the cloned genomic DNA inserts to generate genomic sequence
tags, GSTs. GST sequencing was performed by using a 3700 ABI
capillary electrophoresis DNA sequencer (Applied Biosystems). The
average length of the DNA sequence reads was 700 bp. Further
analysis of the obtained GSTs was performed by sequence homo-
logy comparison to various protein-sequence databases. The DNA
sequences of the obtained GSTs were translated into amino acid
sequences and compared to the National Center for Biotechnology
Information (NCBI) nonredundant protein database by using known
algorithms [38, 39].
A total of 486 Streptomyces refuineus GSTs were generated and
analyzed by sequence comparison with BLAST. Sequence alignments
displaying an E value of at least e-5 were considered as significantly
homologous and retained for further evaluation. One GST clone iden-
tified by BLAST analysis as encoding a fragment of a nonribosomal
peptide synthetase (NRPS) enzyme was selected for the generation
of an oligonucleotide probe, which was then used to identify the
gene cluster harboring this specific NRPS gene(s) in the large insert
cosmid library.r Ltd All rights reserved
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A cosmid library was constructed from the Streptomyces refuineus
high molecular weight genomic DNA by using a SuperCos-1-derived
cosmid vector (STRATAGENE). The cosmid arms were prepared as
specified by the manufacturer. The cosmid library consisted of 864
isolated cosmid clones in E. coli DH10B (Invitrogen). These clones
were picked and inoculated into nine 96-well microtiter plates con-
taining LB broth, which were grown overnight and then adjusted to
contain a final concentration of 25% glycerol. These microtiter plates
were stored at 80C and served as glycerol stocks of the cosmid
library. Duplicate microtiter plates were arrayed onto nylon mem-
branes and crosslinked onto the membranes by UV irradiation by
using a GS GENE LINKER UV Chamber (BIORAD, Inc). Considering
an average size of 8 Mb for an actinomycete genome and an
average size of 35 kb of genomic insert in the cosmid library, this
library represents roughly a 4-fold coverage of the microorganism’s
genome.
A GST clone identified by BLAST analysis as encoding a fragment of
a nonribosomal peptide synthetase (NRPS) enzyme was selected for
the generation of an oligonucleotide probe, which was then used to
identify the gene cluster harboring this specific NRPS gene(s) in the
cosmid library.
Hybridization oligonucleotide probes were radiolabeled with P32 by
using T4 polynucleotide kinase (New England Biolabs, Inc.) in 15 ml re-
actions containing 5 pM of oligonucleotide and 6.6 pM of g-P32 ATP in
the kinase reaction buffer supplied by the manufacturer. Positive
clones were identified, cosmid DNA was extracted from 30 ml cultures
by the alkaline lysis method, and the inserts were entirely sequenced
by a shotgun sequencing approach [40]. Two overlapping cosmid
clones that were detected by the oligonucleotide probe derived from
the original NRPS GST clone were completely sequenced to provide
approximately 60 Kb of information.
Retrofitting Cosmids with Origin of Transfer
To enable gene deletion, cosmids 024CO and O24CA were retrofitted
with oriT by replacing kanamycin resistance gene (neo) with oriT and
streptomycin resistance-gene (aad(A)) cassette from plasmid pIJ778
with primers 50-TCAAGATCTGATCAAGAGACAGGATGAGGATCGTT
TCGCGCGGCATCTTATTTGCCGAC-30 and 50-GCGTCG CTTGGTCG
GTCATTTCGAACCCCAGAGTCCCGCGTTCCCGCCAGCCTCGCAG-
30 (pIJ778 homologous sequence underlined) and then replacing
aad(A) with neo with primers 50-TATGCAGAGG CCGAGGC-30 and
50-TATATCGTGCGAAAAAGGA TGGATATACCGAAAA AATCGCCA
GAGTCCCGCTCAGAAG-30 (neo homologous sequence underlined)
through PCR targeting system. Cosmids 024CO and O24CA contain-
ing the oriT insertion are designated 024OCO and 024OCA, respec-
tively, and used for the disruption of orfS10, orf12, orf19, and NRPS
(orf21/orf22).
Targeted Replacement of orfS10, orf12, orf19, and NRPS
orf21/orf22
Apramycin resistance gene (aac(3)IV) was amplified from plasmid
pIJ773 with forward and reverse primers (Table S1) with flanking re-
gions appropriate for gene replacement. The resulting PCR products
were transformed into E. coli BW25113/pIJ790 containing cosmid
024OCO or 024OCA. orfS10, orf12, orf19 and NRPS (orf21/orf22)
were replaced separately by aac(3)IV, and the resulting cosmids
pBOB3001, pBOB3002, pBOB3003, and pBOB3004were transformed
into E. coli ET12567/pUZ8002 and then introduced into wild-type
S. refuineus strain by intergeneric conjugation. The double-crossover
homologous recombination mutant strains were selected for an apra-
mycin-resistant and kanamycin-sensitive phenotype. orfS10, orf12,
orf19, and NRPS (orf21/orf22) mutants were tested by PCR amplifica-
tion with the primers internal to apramycin-resistance marker aac(3)IV
and to regions external to the replaced genes (Table S2). The corre-
sponding mutants are designated BOB3001, BOB3002, BOB3003,
and BOB3004, separately.Chemistry & Biology 14, 69Targeted Replacement of orf1 and orfAS11
The cassette comprising the apramycin-resistance gene (aac(3)IV) and
oriT was amplified from plasmid pIJ773 with appropriate forward
primers and reverse primers (Table S1). The resulting PCR products
were transformed into E. coli BW25113/pIJ790 containing cosmid
024CO (024CA). orf1 and orfAS11 were replaced separately by aa-
c(3)IV and oriT cassette and the resulting cosmids pBOB3005 and
pBOB3006 were transformed into E. coli ET12567/pUZ8002 and
then introduced into wild-type S. refuineus strain by intergeneric con-
jugation. The double-crossover homologous recombination mutant
strains were selected for by using apramycin-resistant and kanamy-
cin-sensitive phenotypes. orf1 and orfAS11 mutants were tested by
PCR amplification with the primers internal to apramycin resistance
marker aac(3)IV and to regions external to the replaced genes (Table
S2). The corresponding mutants were designated BOB3005 and
BOB3006, separately.
Targeted Replacement of orf23 and orf24
The apramycin resistance gene cassette, containing (aac(3)IV) and
oriT, was amplified from plasmid pIJ773 with forward primers and re-
verse primers (Table S1). The resulting PCR products were trans-
formed into E. coli BW25113/pIJ790 containing cosmid 024CA. Three
hundred and sixty-one base pairs inside orf23 and 360 bp inside orf24
were replaced separately by aac(3)IV and oriT cassette, and the result-
ing cosmids pBOB3007 and pBOB3008 were transformed into E. coli
ET12567/pUZ8002 and then introduced into wild-type S. refuineus
strain by intergeneric conjugation. Apramycin-resistant and kanamy-
cin-sensitive orf23 and orf24 disruption mutants were tested by PCR
amplification with the primers internal to apramycin resistance marker
aac(3)IV and to regions external to the replaced genes (Table S2). The
corresponding mutants were designated BOB3007 and BOB3008.
Production and Detection of Anthramycin
S. refuineus and its mutant derivatives were cultured in 50 ml seed
medium at 47C for 24 hr. A 5% inoculum was then added to 50 ml
production medium (for chemical complementation, corresponding
compounds were added directly to the production medium to a final
concentration of 2 mM beginning of fermentation) and cultured at
47C for 24 hr. Anthramycin was extracted from the production
medium with 50 ml butanol. Butanol extracts were concentrated in
vaccuo and redissolved in MeOH.
Antibacterial activity of anthramycin was detected by thin-layer
chromatography bioautography. Anthramycin butaol extracts (dis-
solved in MeOH) were run on 25DC-Alufolien 20 3 20 cm Kieselgel
plates with solvent MeOH:CHCl3 (1:9); LB agar containing indicator
strain Bacillus sp. TA was overlaid on TLC plates and cultured at
37C for 20 hr to detect anti-Bacillus activity (evidenced by growth
inhibition zones) of anthramycin.
Anthramycin production was further confirmed by HPLC/MS. Mass
spectrometry was performed by using ThermoFinnigan (San Jose, CA)
TSQ Quantum triple quadrupole mass spectrometer equipped with
a standard electrospray ionization source outfitted with a 100 mm
I.D. deactivated fused Si capillary. The injection volume was 10 ml.
Anthramycin was separated from cometabolites by using a Jupiter
minibore 5 mm C18 column (2.0 mm 3 15 cm) with a linear water-
acetonitrile gradient (ranging from 95:5 to 5:95H2O:CH3CN) containing
10 mM ammonium acetate. The flow rate was 0.2 ml/min. The mass
spectrometer was operated in the positive (or negative) ion mode,
and the electrospray needle was maintained at 4,200 V. The ion trans-
fer tube was operated at 35 V and 342C (35 V and 300C for nega-
tive). The tube lens voltage was set to 85 V (220 V for negative).
Source CID (offset voltage between skimmer and the first ion guide,
Q00) was used at 15 V.
Themass spectrometer was operated in full scanmodewith Quad 1.
The mass spectral resolution was set to a peak width of 0.70 u (full
width at half maximum, FWHM). Full scan spectra were acquired
from m/z 150.0 to 700.0 (m/z 150.0 to 1200.0 for negative) over1–701, June 2007 ª2007 Elsevier Ltd All rights reserved 699
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Benzodiazepine Biosynthesis in S. refuineus1.0 s. Data were acquired in profile mode. The electron multiplier gain
was set to 3 3 105.
Supplemental Data
Supplemental Data for this article is available online at http://www.
chembiol.com/cgi/content/full/14/6/691/DC1/.
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